Autonomy Bio is a biotechnology company that is engaged in developing the first human aging drugs.
Autonomy Bio has raised $17.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in March 2025.
Autonomy Bio is headquartered in San Francisco, United States.
Autonomy Bio is a biotechnology company that is engaged in developing the first human aging drugs.
Autonomy Bio is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Autonomy Bio — Funding & Investors." VCBacked, March 27, 2025, https://www.vcbacked.co/company/autonomy-bio. Accessed August 14, 2026.
VCBacked. (2025). Autonomy Bio — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/autonomy-bio
{{cite web |title=Autonomy Bio — Funding & Investors |url=https://www.vcbacked.co/company/autonomy-bio |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated